Login to Your Account

Financings Roundup

Monday, November 19, 2012
• Audeo Oncology Inc., of San Francisco, set the price range for its proposed initial public offering of 3.3 million shares between $14 and $16.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription